December 28, 2023 – The U.S. Preventive Services Task Force posted today a draft research plan on medication to reduce the risk of breast cancer. The draft research plan is available for review and public comment from December 28, 2023, through January 31, 2024. Note the public comment period has been expanded from the standard four weeks to five weeks to account for the holidays. To review the draft research plan and submit comments, go here.
